Similar Papers

Paper Title
Journal
Date
Author
P-108 Automated sperm selection software (SiD) provides similar results as human selection for ICSI
D Montjean ... C Pacios
Human Reproduction | VOL. 39
D Montjean, et. al.D Montjean ... C Pacios
03 Jul 2024
P0739 Treatment persistence, clinical, and biological outcomes following an elective switch from intravenous to subcutaneous infliximab and vedolizumab
A Outtier ...
Journal of Crohn's and Colitis | VOL. 19
A Outtier, et. al.A Outtier ...
22 Jan 2025
Biologic Features and Clinical Outcomes According to Age Groups In Myelodysplastic Syndrome
Seungbum Lee ... Kyoo-Hyung Lee
Blood | VOL. 116
Seungbum Lee, et. al.Seungbum Lee ... Kyoo-Hyung Lee
19 Nov 2010
P507 Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort
R Gadhok ... K Fragkos
Journal of Crohn's and Colitis | VOL. 14
R Gadhok, et. al.R Gadhok ... K Fragkos
15 Jan 2020
View more papers

More From: Biomedicines

Paper Title
Journal
Date
Author
Relationship Between Renal Resistive Index and Retinal Vascular Density in Individuals with Hypertension
Caterina Carollo ... Giulio Geraci
Biomedicines | VOL. -
Caterina Carollo, et. al.Caterina Carollo ... Giulio Geraci
28 Jan 2025
Incidence, Predictors, and Management of Femoral Vascular Complications Following Catheter Ablation for Atrial Fibrillation: A Systematic Duplex Ultrasound Study
Hyo Jin Lee ... Kyoung-Min Park
Biomedicines | VOL. -
Hyo Jin Lee, et. al.Hyo Jin Lee ... Kyoung-Min Park
28 Jan 2025
Decoding Ecuadorian Mycobacterium tuberculosis Isolates: Unveiling Lineage-Associated Signatures in Beta-Lactamase Resistance via Pangenome Analysis
Gabriel Morey-León ... Luisa Berná
Biomedicines | VOL. -
Gabriel Morey-León, et. al.Gabriel Morey-León ... Luisa Berná
28 Jan 2025
Linear and Non-Linear Optimal Control Methods to Determine the Best Chemotherapy Schedule for Most Effectively Inhibiting Tumor Growth
Sotirios G Liliopoulos ... Konstantinos S Dimas
Biomedicines | VOL. -
Sotirios G Liliopoulos, et. al.Sotirios G Liliopoulos ... Konstantinos S Dimas
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.